Barbara Ann Karmanos Cancer Institute赞助的临床试验
总计8059个结果
-
Shandong Cancer Hospital and Institute未知
-
Shandong Cancer Hospital and Institute撤销
-
Shandong Cancer Hospital and Institute完全的
-
Shandong Cancer Hospital and Institute未知肝病 | 组织学类型的肿瘤 | 按部位分类的肿瘤 | 腺癌 | 癌 | 肿瘤、腺体和上皮 | 消化系统肿瘤 | 癌,肝细胞癌 | 肝脏肿瘤 | 乙肝病毒 | 苯妥英/索拉非尼 [VA 药物相互作用] | 阿霉素/曲妥珠单抗 [VA 药物相互作用]中国
-
Shandong Cancer Hospital and Institute招聘中
-
Shandong Cancer Hospital and Institute尚未招聘乳腺癌女性 | 患者报告的结果 | 保乳手术 | 肿瘤安全
-
Shandong Cancer Hospital and Institute未知
-
Shandong Cancer Hospital and Institute未知
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH); University of Utah完全的
-
Shandong Cancer Hospital and InstitutePeking University Cancer Hospital & Institute未知
-
Cancer Prevention and Research Institute, ItalyIstituto Toscano Tumori未知
-
H. Lee Moffitt Cancer Center and Research InstituteAbramson Cancer Center at Penn Medicine完全的
-
H. Lee Moffitt Cancer Center and Research InstitutePfizer招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteAmgen主动,不招人
-
H. Lee Moffitt Cancer Center and Research InstituteExelixis完全的
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZeneca终止
-
H. Lee Moffitt Cancer Center and Research InstituteBayer完全的
-
H. Lee Moffitt Cancer Center and Research InstitutePfizer完全的
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKline完全的
-
H. Lee Moffitt Cancer Center and Research InstituteSanofi终止
-
H. Lee Moffitt Cancer Center and Research InstituteBayer完全的
-
H. Lee Moffitt Cancer Center and Research InstitutePfizer完全的